Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We use our state-of-the-art dedicated workflow for designing focused libraries for receptors.
Fig. 1. The sreening workflow of Receptor.AI
This includes comprehensive molecular simulations of the receptor in its native membrane environment, paired with ensemble virtual screening that factors in its conformational mobility. In cases involving dimeric or oligomeric receptors, the entire functional complex is modelled, pinpointing potential binding pockets on and between the subunits to capture the full range of mechanisms of action.
Our library stands out due to several important features:
partner
Reaxense
upacc
O14763
UPID:
TR10B_HUMAN
Alternative names:
Death receptor 5; TNF-related apoptosis-inducing ligand receptor 2
Alternative UPACC:
O14763; O14720; O15508; O15517; O15531; Q6UXM8; Q7Z360; Q9BVE0
Background:
Tumor necrosis factor receptor superfamily member 10B, also known as Death receptor 5 and TNF-related apoptosis-inducing ligand receptor 2, plays a pivotal role in apoptosis. It acts as a receptor for the cytotoxic ligand TNFSF10/TRAIL, initiating a cascade of caspases mediating apoptosis and promoting NF-kappa-B activation. Essential for ER stress-induced apoptosis, its function underscores the balance between cell survival and death.
Therapeutic significance:
Squamous cell carcinoma of the head and neck, a non-melanoma skin cancer, may be influenced by variants affecting this protein. Understanding the role of Tumor necrosis factor receptor superfamily member 10B could open doors to potential therapeutic strategies targeting this malignancy.